Age-stratified serosurvey reveals immunity patterns against measles in Youyang, China
Frontiers in Public Health · 21.07.2026 · 14
DOI: 10.3389/fpubh.2026.1888095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 21.07.2026. Verfasst von Siyu Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Dis…. Hauptthemen laut MEDLINE: Measles, Antibodies, Viral, Measles Vaccine. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate age-specific measles antibody dynamics and identify population immunity gaps in Youyang County, China, approximately two decades after the introduction of a two-dose measles-containing vaccine (MCV) schedule at 8 and 18 months of age.
Methods
A cross-sectional serosurvey was conducted among residents without rash in 2025. Measles-specific IgG antibodies were quantified using enzyme-linked immunosorbent assay (ELISA), with seroprevalence defined as >200 mIU/mL. Seroprevalence and geometric mean concentrations (GMCs) were analyzed across eight age strata.
Results
Among 608 participants, the crude overall seroprevalence was 76.5% (IPW-adjusted rate: 81.5%), with significant age-specific variation ( p < 0.001). The lowest levels were observed in infants aged <8 months (36.5, 95%CI: 26.2–47.9; GMC: 120.47 mIU/mL). Following two vaccine doses, peak immunity was achieved in children aged 18 months to <6 years (>95%; GMC: 730.99–1044.61 mIU/mL). Seroprevalence then reached a distinct nadir in adults aged 18–<40 years (65.6, 95% CI: 50.9–77.9; GMC: 330.48 mIU/mL), before rebounding in older adults aged ≥40 years (90.1–93.5%).
Conclusion
This investigation revealed a distinct immunity gap, with measles adjusted seroprevalence at 36.5% (95% CI: 26.2–47.9) in infants under 8 months and 65.6% (95% CI: 50.9–77.9) in reproductive-aged adults, despite robust post-vaccination responses in young children. This serological pattern may be a common characteristic in populations that complete two-dose MCV immunization by 18 months of age and experience persistently low measles incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of P…
- Clinical Laboratory, Youyang Hospital, A Branch of The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zitieren
APA
Chen, S., Wang, T., Liu, K., Wang, Q., Shi, W., Cheng, X., & Yao, K. (2026). Age-stratified serosurvey reveals immunity patterns against measles in Youyang, China. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1888095
Vancouver
Chen S, Wang T, Liu K, Wang Q, Shi W, Cheng X, et al. Age-stratified serosurvey reveals immunity patterns against measles in Youyang, China. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1888095
BibTeX
@article{Chen2026,
author = {Chen, Siyu and Wang, Tianlan and Liu, Kaiwei and Wang, Qing and Shi, Wei and Cheng, Xiaoping and Yao, Kaihu},
title = {Age-stratified serosurvey reveals immunity patterns against measles in Youyang, China},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1888095}
}
EUVIMED